Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P50
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-24.31%
2024-230.11%
2023-156.57%
2022123.69%
2021-215.07%
2020-565.03%
201968.95%
2018-4413.04%
201797.61%
2016-6.02%